All clinical management guidelines

AHMF clinical guidelines provide diagnosis and management information for conditions caused by herpesviruses.

  • Counselling and communication skills for patients with genital herpes
    Mar 2000
    May 2009

    While good communication and counselling skills play an important part in the management of all kinds of patient difficulties, for the patient with genital herpes, or any sexually transmissible infection, they are particularly important.

  • Short course therapy for recurrrent herpes simplex
    Sep 2008
    May 2009

    Short (two-day) course treatment for recurrent genital herpes was approved in Australia in 2008. If patient-initiated at the onset of symptoms, this form of treatment can be as effective as the more established five-day course.

  • Managing genital herpes
    Sep 1998
    May 2009

    Genital herpes is under-recognised and under-treated.More than three-quarters of people with genital herpes simplex virus infection do not receive appropriate therapy for their condition because the infection has not been recognised or properly diagnosed.

  • Reducing the sexual transmission of genital herpes
    Mar 2004
    May 2009

    People diagnosed with genital herpes usually have many questions and concerns, a key one being anxiety about possible transmission of the infection to a partner. Similarly, an uninfected partner is often anxious about the possibility of acquiring genital herpes from the infected person.

  • The diagnosis of herpes simplex viruses
    Jun 2006
    May 2009

    HSV infections are often diagnosed clinically, but laboratory diagnosis is required for prescribing antiviral medications under Australia's Pharmaceutical Benefits Scheme. Diagnosis can be confirmed with one of four methods in Australia: viral isolation, direct antigen detection, PCR and type-specific serology.

  • Type-specific serology for the diagnosis of genital herpes
    Sep 2000
    May 2009

    There are now a number of simple commercially available ELISA tests for type-specific HSV infection. These test are relatively simple to perform in the laboratory, and are now being produced by a number of companies.

  • Herpes simplex in pregnancy
    Jun 2004
    May 2009

    Vertical transmission of HSV from mother to child can result in neonatal herpes, a rare condition—but with very high mortality. This guidelines examines strategies for reducing the incidence of this condition.

  • Suppressive therapy for genital herpes
    May 2008
    May 2009

    Most genital herpes is caused by the herpes simplex virus 2 (HSV-2), although herpes simplex virus 1 (HSV-1) accounts for half the new cases in developed countries. The major concern of HSV is its frequency of recurrences, its chronicity and its effects on patient personal relationships while asymptomatic shedding is an important source of transmission of the virus to other susceptible individuals.

  • HSV in HIV-Infected individuals
    Sep 2008
    May 2009

    There are a number of ways in which HSV and HIV interact, first to enhance transmission of both viruses, and second in a number of clinical manifestations.

  • The diagnosis of herpes simplex viruses
    Jun 2006
    May 2009

    HSV infections are often diagnosed clinically, but laboratory diagnosis is required for prescribing antiviral medications under Australia's Pharmaceutical Benefits Scheme. Diagnosis can be confirmed with one of four methods in Australia: viral isolation, direct antigen detection, PCR and type-specific serology.

  • Managing oral herpes
    Dec 1998
    May 2009

    Oral herpes is the cause of cold sores, a recurrent and unsightly condition affecting millions of Australians. This guidelines discusses diagnosis, management (topical and oral), transmission, complications and pathogenesis.

  • Overview of varicella zoster virus
    May 2006

    Varicella zoster virus (VZV) is a unique member of the Herpesviridae family, as it can infect both skin and nerves and develop latent infection within the dorsal root and trigeminal ganglia. Infection with this virus is common and causes a wide range of clinical syndromes. Although this virus infects healthy children and adults, disease is more severe and extensive in the immunocompromised.

  • Managing herpes zoster
    Jan 1998
    May 2009

    Herpes zoster, commonly known as shingles, causes a painful rash which can have significant and long-standing consequences. Treating the rash quickly reduces its painfulness and duration and minimises the likelihood of debilitating sequelae.

  • Overview of varicella zoster virus
    May 2006

    Varicella zoster virus (VZV) is a unique member of the Herpesviridae family, as it can infect both skin and nerves and develop latent infection within the dorsal root and trigeminal ganglia. Infection with this virus is common and causes a wide range of clinical syndromes. Although this virus infects healthy children and adults, disease is more severe and extensive in the immunocompromised.

  • Herpes zoster vaccination
    Apr 2008

    The recently-approved herpes zoster vaccine has been shown to significantly reduce both the incidence and the severity of herpes zoster (shingles) in older people. This guideline discusses the efficacy of and indications for vaccination.

  • Managing herpes zoster
    Jan 1998
    May 2009

    Herpes zoster, commonly known as shingles, causes a painful rash which can have significant and long-standing consequences. Treating the rash quickly reduces its painfulness and duration and minimises the likelihood of debilitating sequelae.

  • Herpes simplex in pregnancy
    Jun 2004
    May 2009

    Vertical transmission of HSV from mother to child can result in neonatal herpes, a rare condition—but with very high mortality. This guidelines examines strategies for reducing the incidence of this condition.

  • Herpes infections of the eye
    Jul 2006
    May 2009

    Herpes infections of the eye include keratitis, corneal dendrites, corneal scarring, uveitis, acute retinitis, chronic conjunctivitis and neurotrophic keratopathy. The principal challenge for clinicians is tailoring the management to the type of damage.

  • HSV in HIV-Infected individuals
    Sep 2008
    May 2009

    There are a number of ways in which HSV and HIV interact, first to enhance transmission of both viruses, and second in a number of clinical manifestations.

Disclaimer

The AHMF have made considerable efforts to ensure the information upon which this guideline is based reproduces the evidence as accurately as possible. Users of this guideline are strongly recommended to confirm that the information contained within it, especially drug indications, is correct by way of independent sources, as this guideline does not indicate an exclusive course of action or serve as a standard of medical care. The AHMF accepts no responsibility for any inaccuracies, information perceived as misleading, or success of any treatment regime detailed in this guideline.

Australian Herpes Management Forum, c/- STIRC, Marian Villa, Westmead Hospital, Westmead NSW 2145, Australia.

Telephone: +61 (2) 8230 3843 - Fax: +61 (2) 9845 6287

Contact AHMF by email - ACN 096 346 477 - ABN 85 096 346 477